93 related articles for article (PubMed ID: 27275252)
1. Association between VNTR Polymorphism in Promoter Region of Prodynorphin (PDYN) Gene and Methamphetamine Dependence.
Saify K; Saadat M
Open Access Maced J Med Sci; 2015 Sep; 3(3):371-3. PubMed ID: 27275252
[TBL] [Abstract][Full Text] [Related]
2. Genetic variant of prodynorphin gene is risk factor for methamphetamine dependence.
Nomura A; Ujike H; Tanaka Y; Otani K; Morita Y; Kishimoto M; Morio A; Harano M; Inada T; Yamada M; Komiyama T; Sekine Y; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
Neurosci Lett; 2006 May; 400(1-2):158-62. PubMed ID: 16529859
[TBL] [Abstract][Full Text] [Related]
3. Association between VNTR polymorphism in promoter region of prodynorphin (PDYN) gene and heroin dependence.
Saify K; Saadat I; Saadat M
Psychiatry Res; 2014 Nov; 219(3):690-2. PubMed ID: 25048760
[TBL] [Abstract][Full Text] [Related]
4. Prodynorphin (PDYN) gene polymorphisms in Turkish patients with methamphetamine use disorder, changes in PDYN serum levels in withdrawal and the relationship between PDYN, temperament and depression.
Şenormancı G; Turan Ç; Çelik SK; Çelik A; Edgünlü TG; Akbaş D; Akca ASD; Şenormancı Ö
J Ethn Subst Abuse; 2022; 21(2):522-537. PubMed ID: 32597371
[TBL] [Abstract][Full Text] [Related]
5. Genetic association analyses and meta-analysis of Dynorphin-Kappa Opioid system potential functional variants with heroin dependence.
Yuanyuan J; Rui S; Hua T; Jingjing C; Cuola D; Yuhui S; Shuguang W
Neurosci Lett; 2018 Oct; 685():75-82. PubMed ID: 30138645
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of prodynorphin gene polymorphisms and their association with heroin addiction in a sample of the southeast Iranian population.
Hashemi M; Shakiba M; Sanaei S; Shahkar G; Rezaei M; Mojahed A; Bahari G
Mol Biol Res Commun; 2018 Mar; 7(1):1-6. PubMed ID: 29911117
[TBL] [Abstract][Full Text] [Related]
7. Association of variants of prodynorphin promoter 68-bp repeats in caucasians with opioid dependence diagnosis: Effect on age trajectory of heroin use.
Yuferov V; Randesi M; Butelman ER; van den Brink W; Blanken P; van Ree JM; Ott J; Kreek MJ
Neurosci Lett; 2019 Jun; 704():100-105. PubMed ID: 30936032
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility to gastric cancer and polymorphisms of insertion/deletion at the intron 3 of the XRCC4 and VNTR at the promoter region of the XRCC5.
Saadat M; Pashaei S; Amerizade F
Pathol Oncol Res; 2015 Jul; 21(3):689-93. PubMed ID: 25527410
[TBL] [Abstract][Full Text] [Related]
9. Association between heroin dependence and prodynorphin gene polymorphisms.
Wei SG; Zhu YS; Lai JH; Xue HX; Chai ZQ; Li SB
Brain Res Bull; 2011 May; 85(3-4):238-42. PubMed ID: 21382455
[TBL] [Abstract][Full Text] [Related]
10. Association between
Khalighinasab MR; Saify K; Saadat M
Mol Biol Res Commun; 2015 Jan; 4(1):25-32. PubMed ID: 27843993
[TBL] [Abstract][Full Text] [Related]
11. Confirmation of the association between a polymorphism in the promoter region of the prodynorphin gene and cocaine dependence.
Dahl JP; Weller AE; Kampman KM; Oslin DW; Lohoff FW; Ferraro TN; O'Brien CP; Berrettini WH
Am J Med Genet B Neuropsychiatr Genet; 2005 Nov; 139B(1):106-8. PubMed ID: 16184603
[TBL] [Abstract][Full Text] [Related]
12. Gender-specific association of functional
Yuferov V; Butelman ER; Kreek MJ
Neuropsychiatr Dis Treat; 2018; 14():1025-1034. PubMed ID: 29713172
[TBL] [Abstract][Full Text] [Related]
13. Prodynorphin gene promoter polymorphism and temporal lobe epilepsy: A meta-analysis.
Zhang N; Ouyang TH; Zhou Q; Kang HC; Zhu SQ
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):635-639. PubMed ID: 26489614
[TBL] [Abstract][Full Text] [Related]
14. The expression of prodynorphin gene is down-regulated by activation with lipopolysaccharide in U-937 macrophage cells.
Sun B; Tipton CM; Bidlack JM
J Neuroimmunol; 2006 May; 174(1-2):52-62. PubMed ID: 16483672
[TBL] [Abstract][Full Text] [Related]
15. A functional prodynorphin promoter polymorphism and opioid dependence.
Ray R; Doyle GA; Crowley JJ; Buono RJ; Oslin DW; Patkar AA; Mannelli P; DeMaria PA; O'Brien CP; Berrettini WH
Psychiatr Genet; 2005 Dec; 15(4):295-8. PubMed ID: 16314761
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the prodynorphin promoter polymorphism in atopic dermatitis and disease-related pruritus.
Greisenegger EK; Zimprich A; Zimprich F; Stingl G; Kopp T
Clin Exp Dermatol; 2009 Aug; 34(6):728-30. PubMed ID: 19486061
[TBL] [Abstract][Full Text] [Related]
17. A functional polymorphism in the prodynorphin gene affects cognitive flexibility and brain activation during reversal learning.
Votinov M; Pripfl J; Windischberger C; Moser E; Sailer U; Lamm C
Front Behav Neurosci; 2015; 9():172. PubMed ID: 26190983
[TBL] [Abstract][Full Text] [Related]
18. Prodynorphin transcripts and proteins differentially expressed and regulated in the adult human brain.
Nikoshkov A; Hurd YL; Yakovleva T; Bazov I; Marinova Z; Cebers G; Pasikova N; Gharibyan A; Terenius L; Bakalkin G
FASEB J; 2005 Sep; 19(11):1543-5. PubMed ID: 16014400
[TBL] [Abstract][Full Text] [Related]
19. Effect of adenoviral delivery of prodynorphin gene on experimental inflammatory pain induced by formalin in rats.
Chen X; Wang T; Lin C; Chen B
Int J Clin Exp Med; 2014; 7(12):4877-86. PubMed ID: 25663984
[TBL] [Abstract][Full Text] [Related]
20. [Case-control, family based and screening for DNA sequence variation in the dopamine transporter gene polymorphism DAT 1 in alcohol dependence].
Grzywacz A; Samochowiec J
Psychiatr Pol; 2008; 42(3):443-52. PubMed ID: 19899571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
